{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:49:24Z","timestamp":1761166164631,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.anndiagpath.2020.151636","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T11:14:51Z","timestamp":1600514091000},"page":"151636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma"],"prefix":"10.1016","volume":"49","author":[{"given":"Kirill A.","family":"Lyapichev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sakhdari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis P.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siba","family":"El Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron C.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyur P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergej","family":"Konoplev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151636_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri1529","article-title":"WNT signalling and haematopoiesis: a WNT-WNT situation","volume":"5","author":"Staal","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"10.1016\/j.anndiagpath.2020.151636_bb0010","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.ejca.2009.08.003","article-title":"Targeting the WNT\/beta-catenin\/TCF\/LEF1 axis in solid and haematological cancers: multiplicity of therapeutic options","volume":"45","author":"Gehrke","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151636_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","article-title":"LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma","volume":"68","author":"Menter","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151636_bb0020","first-page":"292","article-title":"Diagnostic utility of lymphoid enhancer binding factor 1 immunohistochemistry in small B-cell lymphomas","volume":"147","author":"Menter","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151636_bb0025","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151636_bb0030","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","article-title":"Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt\u2019s lymphoma","volume":"182","author":"Walther","year":"2013","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151636_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/leu.2016.232","article-title":"Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma","volume":"31","author":"Linke","year":"2017","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.anndiagpath.2020.151636_bb0040","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1182\/blood-2017-07-794826","article-title":"Classical Hodgkin lymphoma arising in a patient with chronic lymphocytic leukemia (Richter syndrome)","volume":"130","author":"Quesada","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.anndiagpath.2020.151636_bb0045","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.18632\/oncotarget.23824","article-title":"Epstein-Barr virus stably confers an invasive phenotype to epithelial cells through reprogramming of the WNT pathway","volume":"9","author":"Birdwell","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151636_bb0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.leu.2400609","article-title":"Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil","volume":"11","author":"Sandlund","year":"1997","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151636_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.anndiagpath.2020.151636_bb0060","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151636_bb0065","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151636_bb0070","first-page":"285","article-title":"Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia","volume":"4","author":"Richter","year":"1928","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151636_bb0075","first-page":"621","article-title":"Chronic lymphoid leukemia secondarily associated with a malignant reticulopathy: Richter\u2019s syndrome","volume":"4","author":"Lortholary","year":"1964","journal-title":"Nouv Rev Fr Hematol"},{"year":"2017","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.anndiagpath.2020.151636_bb0080"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151636_bb0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajh.23939","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: incidence, outcomes, and comparison to de novo Hodgkin lymphoma","volume":"90","author":"Parikh","year":"2015","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151636_bb0090","first-page":"785","article-title":"Hodgkin\u2019s variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group","volume":"34","author":"Tadmor","year":"2014","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151636_bb0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ajh.24714","article-title":"Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma","volume":"92","author":"Mauro","year":"2017","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2020.151636_bb0100","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","article-title":"Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases","volume":"24","author":"Shao","year":"2011","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151636_bb0105","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1309\/AJCPWQ0I0DGXBMHO","article-title":"Transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone","volume":"132","author":"Fraser","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"21","key":"10.1016\/j.anndiagpath.2020.151636_bb0110","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2017-08-802900","article-title":"\u201cSoccer ball\u201d cells to \u201cdonut\u201d cells: an unusual case of Richter syndrome","volume":"130","author":"Thakral","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151636_bb0115","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter\u2019s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151636_bb0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.leu.2403249","article-title":"Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter\u2019s syndrome","volume":"18","author":"Timar","year":"2004","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151636_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ajcp\/93.3.333","article-title":"Hodgkin\u2019s disease variant of Richter\u2019s syndrome. Report of eight cases","volume":"93","author":"Brecher","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151636_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","article-title":"Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion","volume":"55","author":"Xiao","year":"2016","journal-title":"Hum Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:33Z","timestamp":1761078813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420301829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":26,"alternative-id":["S1092913420301829"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151636","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151636"}}